| Machine Learning for Colorectal Cancer Risk Prediction |
Ling Zheng |
Monmouth University |
PLCO |
Nov 17, 2020 |
PLCO-687 |
| Evaluate the impact of ovarian cancer interventions for primary prevention, screening and treatment |
Iakovos Toumazis |
The University of Texas MD Anderson Cancer Center |
PLCO |
Nov 17, 2020 |
PLCO-689 |
| Using clinicopathological data to determine risk of metachronous advanced colorectal neoplasia among patients with adenomas |
Laura Hester |
Janssen Research and Development, LLC |
PLCO |
Nov 17, 2020 |
PLCO-688 |
| An examination of the relationship between specific driver mutations, target drugs, and immunotherapies in non-small cell lung cancer survival outcomes. |
Lauren Connell |
Independent |
PLCO |
Nov 17, 2020 |
PLCO-691 |
| Heterogeneous Odds Ratio Estimation |
Jean Pauphilet |
London Business School |
PLCO |
Nov 4, 2020 |
PLCO-686 |
| Evaluating key determinants for the risk of second primary lung cancer among breast and colorectal cancer survivors using population-based screening trial data from the PLCO |
Summer Han |
Stanford University |
PLCO |
Oct 27, 2020 |
PLCO-683 |
| Statistical Methods and Artificial Intelligence Deep Learning to Identify the Risk Factors of Colorectal Cancer |
Ranju Karki |
University of South Florida |
PLCO |
Oct 27, 2020 |
PLCO-684 |
| Statistical Modelling on Pancreatic Cancer |
ADITYA CHAKRABORTY |
University of south Florida |
PLCO |
Oct 22, 2020 |
PLCO-680 |
| Investigating multi-modal signatures of clinical outcome to immunotherapy in renal cell carcinoma |
Sachet Shukla |
Dana-Farber Cancer Institute |
PLCO |
Oct 22, 2020 |
PLCO-679 |
| Statistical methods to identify the “causal SNP” from among SNPs in high LD with an index SNP |
Mitchell Gail |
National Cancer Institute |
PLCO |
Oct 22, 2020 |
PLCO-678 |
| Predicting time to castration resistance in hormone sensitive prostate cancer |
Ari Robinson |
The Institute for Medical BioMathematics (IMBM) |
PLCO |
Oct 22, 2020 |
PLCO-677 |
| Assessing the Risk and Cost of the Digital Rectal Exam: Is It Time to Abandon the DRE? |
Sanoj Punnen |
University of Miami Miller School of Medicine |
PLCO |
Oct 8, 2020 |
PLCO-671 |
| Biological bases of lung cancer risk disparities for African American male smokers |
Chengguo Xing |
University of Florida |
PLCO |
Oct 8, 2020 |
PLCO-673 |
| Clonal mosaic chromosomal alterations and mortality in PLCO |
Mitchell Machiela |
National Cancer Institute |
PLCO |
Oct 8, 2020 |
PLCO-674 |
| The impact of diabetes on lung cancer incidence and prognosis according to histologic subtype |
Amanda Leiter |
Icahn School of Medicine at Mount Sinai |
PLCO |
Sep 22, 2020 |
PLCO-668 |
| Serum levels of per- and polyfluorinated substances and risks of non-Hodgkin lymphoma and thyroid cancer |
Mark Purdue |
DCEG, NCI |
PLCO |
Sep 18, 2020 |
2020-0003 |
| Cancer survival analysis using semisupervised learning method based on Cox and AFT models with L1/2 regularization |
Vaishali Gadhiya |
Laurentian University |
PLCO |
Sep 16, 2020 |
PLCO-666 |
| Characteristics associated with weightlifting, cancer risk and associated mortality |
Jessica Gorzelitz |
NCI / DCEG / MEB |
PLCO |
Sep 10, 2020 |
PLCO-665 |
| DNA methylation and breast cancer risk |
Jirong Long |
Vanderbilt University Medical Center |
PLCO |
Sep 1, 2020 |
PLCO-663 |
| Consumption of sugar, sugar-sweetened beverages and liver cancer |
Katherine McGlynn |
National Cancer Institute |
PLCO |
Sep 1, 2020 |
PLCO-664 |
